Article
The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes.
Progress in neurobiology - 1 Sept 2011
Drago Antonio, Crisafulli Concetta, Sidoti Antonina, Serretti Alessandro
Abstract excerpt
The glutamatergic pathway has been consistently involved in the physiopathology of depressive disorder. However a complete dissection and integration of its role in the context of other known mechanisms is lacking. We summarized and integrated the evidence of various levels of interaction between glutamatergic and monoaminergic pathways (see videos). We identified six molecular pathways, some of which with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
